Cargando…

Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study

BACKGROUND: Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations. METHODS AND FINDINGS: Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 inci...

Descripción completa

Detalles Bibliográficos
Autores principales: Forouhi, Nita G., Imamura, Fumiaki, Sharp, Stephen J., Koulman, Albert, Schulze, Matthias B., Zheng, Jusheng, Ye, Zheng, Sluijs, Ivonne, Guevara, Marcela, Huerta, José María, Kröger, Janine, Wang, Laura Yun, Summerhill, Keith, Griffin, Julian L., Feskens, Edith J. M., Affret, Aurélie, Amiano, Pilar, Boeing, Heiner, Dow, Courtney, Fagherazzi, Guy, Franks, Paul W., Gonzalez, Carlos, Kaaks, Rudolf, Key, Timothy J., Khaw, Kay Tee, Kühn, Tilman, Mortensen, Lotte Maxild, Nilsson, Peter M., Overvad, Kim, Pala, Valeria, Palli, Domenico, Panico, Salvatore, Quirós, J. Ramón, Rodriguez-Barranco, Miguel, Rolandsson, Olov, Sacerdote, Carlotta, Scalbert, Augustin, Slimani, Nadia, Spijkerman, Annemieke M. W., Tjonneland, Anne, Tormo, Maria-Jose, Tumino, Rosario, van der A, Daphne L., van der Schouw, Yvonne T., Langenberg, Claudia, Riboli, Elio, Wareham, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951144/
https://www.ncbi.nlm.nih.gov/pubmed/27434045
http://dx.doi.org/10.1371/journal.pmed.1002094
_version_ 1782443651002007552
author Forouhi, Nita G.
Imamura, Fumiaki
Sharp, Stephen J.
Koulman, Albert
Schulze, Matthias B.
Zheng, Jusheng
Ye, Zheng
Sluijs, Ivonne
Guevara, Marcela
Huerta, José María
Kröger, Janine
Wang, Laura Yun
Summerhill, Keith
Griffin, Julian L.
Feskens, Edith J. M.
Affret, Aurélie
Amiano, Pilar
Boeing, Heiner
Dow, Courtney
Fagherazzi, Guy
Franks, Paul W.
Gonzalez, Carlos
Kaaks, Rudolf
Key, Timothy J.
Khaw, Kay Tee
Kühn, Tilman
Mortensen, Lotte Maxild
Nilsson, Peter M.
Overvad, Kim
Pala, Valeria
Palli, Domenico
Panico, Salvatore
Quirós, J. Ramón
Rodriguez-Barranco, Miguel
Rolandsson, Olov
Sacerdote, Carlotta
Scalbert, Augustin
Slimani, Nadia
Spijkerman, Annemieke M. W.
Tjonneland, Anne
Tormo, Maria-Jose
Tumino, Rosario
van der A, Daphne L.
van der Schouw, Yvonne T.
Langenberg, Claudia
Riboli, Elio
Wareham, Nicholas J.
author_facet Forouhi, Nita G.
Imamura, Fumiaki
Sharp, Stephen J.
Koulman, Albert
Schulze, Matthias B.
Zheng, Jusheng
Ye, Zheng
Sluijs, Ivonne
Guevara, Marcela
Huerta, José María
Kröger, Janine
Wang, Laura Yun
Summerhill, Keith
Griffin, Julian L.
Feskens, Edith J. M.
Affret, Aurélie
Amiano, Pilar
Boeing, Heiner
Dow, Courtney
Fagherazzi, Guy
Franks, Paul W.
Gonzalez, Carlos
Kaaks, Rudolf
Key, Timothy J.
Khaw, Kay Tee
Kühn, Tilman
Mortensen, Lotte Maxild
Nilsson, Peter M.
Overvad, Kim
Pala, Valeria
Palli, Domenico
Panico, Salvatore
Quirós, J. Ramón
Rodriguez-Barranco, Miguel
Rolandsson, Olov
Sacerdote, Carlotta
Scalbert, Augustin
Slimani, Nadia
Spijkerman, Annemieke M. W.
Tjonneland, Anne
Tormo, Maria-Jose
Tumino, Rosario
van der A, Daphne L.
van der Schouw, Yvonne T.
Langenberg, Claudia
Riboli, Elio
Wareham, Nicholas J.
author_sort Forouhi, Nita G.
collection PubMed
description BACKGROUND: Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations. METHODS AND FINDINGS: Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 incident T2D cases and 15,919 subcohort participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct study across eight European countries. Country-specific hazard ratios (HRs) were estimated using Prentice-weighted Cox regression and pooled by random-effects meta-analysis. We also systematically reviewed published prospective studies on circulating PUFAs and T2D risk and pooled the quantitative evidence for comparison with results from EPIC-InterAct. In EPIC-InterAct, among long-chain n-3 PUFAs, α-linolenic acid (ALA) was inversely associated with T2D (HR per standard deviation [SD] 0.93; 95% CI 0.88–0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associated. Among n-6 PUFAs, linoleic acid (LA) (0.80; 95% CI 0.77–0.83) and eicosadienoic acid (EDA) (0.89; 95% CI 0.85–0.94) were inversely related, and arachidonic acid (AA) was not significantly associated, while significant positive associations were observed with γ-linolenic acid (GLA), dihomo-GLA, docosatetraenoic acid (DTA), and docosapentaenoic acid (n6-DPA), with HRs between 1.13 to 1.46 per SD. These findings from EPIC-InterAct were broadly similar to comparative findings from summary estimates from up to nine studies including between 71 to 2,499 T2D cases. Limitations included potential residual confounding and the inability to distinguish between dietary and metabolic influences on plasma phospholipid PUFAs. CONCLUSIONS: These large-scale findings suggest an important inverse association of circulating plant-origin n-3 PUFA (ALA) but no convincing association of marine-derived n3 PUFAs (EPA and DHA) with T2D. Moreover, they highlight that the most abundant n6-PUFA (LA) is inversely associated with T2D. The detection of associations with previously less well-investigated PUFAs points to the importance of considering individual fatty acids rather than focusing on fatty acid class.
format Online
Article
Text
id pubmed-4951144
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49511442016-08-08 Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study Forouhi, Nita G. Imamura, Fumiaki Sharp, Stephen J. Koulman, Albert Schulze, Matthias B. Zheng, Jusheng Ye, Zheng Sluijs, Ivonne Guevara, Marcela Huerta, José María Kröger, Janine Wang, Laura Yun Summerhill, Keith Griffin, Julian L. Feskens, Edith J. M. Affret, Aurélie Amiano, Pilar Boeing, Heiner Dow, Courtney Fagherazzi, Guy Franks, Paul W. Gonzalez, Carlos Kaaks, Rudolf Key, Timothy J. Khaw, Kay Tee Kühn, Tilman Mortensen, Lotte Maxild Nilsson, Peter M. Overvad, Kim Pala, Valeria Palli, Domenico Panico, Salvatore Quirós, J. Ramón Rodriguez-Barranco, Miguel Rolandsson, Olov Sacerdote, Carlotta Scalbert, Augustin Slimani, Nadia Spijkerman, Annemieke M. W. Tjonneland, Anne Tormo, Maria-Jose Tumino, Rosario van der A, Daphne L. van der Schouw, Yvonne T. Langenberg, Claudia Riboli, Elio Wareham, Nicholas J. PLoS Med Research Article BACKGROUND: Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations. METHODS AND FINDINGS: Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 incident T2D cases and 15,919 subcohort participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct study across eight European countries. Country-specific hazard ratios (HRs) were estimated using Prentice-weighted Cox regression and pooled by random-effects meta-analysis. We also systematically reviewed published prospective studies on circulating PUFAs and T2D risk and pooled the quantitative evidence for comparison with results from EPIC-InterAct. In EPIC-InterAct, among long-chain n-3 PUFAs, α-linolenic acid (ALA) was inversely associated with T2D (HR per standard deviation [SD] 0.93; 95% CI 0.88–0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associated. Among n-6 PUFAs, linoleic acid (LA) (0.80; 95% CI 0.77–0.83) and eicosadienoic acid (EDA) (0.89; 95% CI 0.85–0.94) were inversely related, and arachidonic acid (AA) was not significantly associated, while significant positive associations were observed with γ-linolenic acid (GLA), dihomo-GLA, docosatetraenoic acid (DTA), and docosapentaenoic acid (n6-DPA), with HRs between 1.13 to 1.46 per SD. These findings from EPIC-InterAct were broadly similar to comparative findings from summary estimates from up to nine studies including between 71 to 2,499 T2D cases. Limitations included potential residual confounding and the inability to distinguish between dietary and metabolic influences on plasma phospholipid PUFAs. CONCLUSIONS: These large-scale findings suggest an important inverse association of circulating plant-origin n-3 PUFA (ALA) but no convincing association of marine-derived n3 PUFAs (EPA and DHA) with T2D. Moreover, they highlight that the most abundant n6-PUFA (LA) is inversely associated with T2D. The detection of associations with previously less well-investigated PUFAs points to the importance of considering individual fatty acids rather than focusing on fatty acid class. Public Library of Science 2016-07-19 /pmc/articles/PMC4951144/ /pubmed/27434045 http://dx.doi.org/10.1371/journal.pmed.1002094 Text en © 2016 Forouhi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Forouhi, Nita G.
Imamura, Fumiaki
Sharp, Stephen J.
Koulman, Albert
Schulze, Matthias B.
Zheng, Jusheng
Ye, Zheng
Sluijs, Ivonne
Guevara, Marcela
Huerta, José María
Kröger, Janine
Wang, Laura Yun
Summerhill, Keith
Griffin, Julian L.
Feskens, Edith J. M.
Affret, Aurélie
Amiano, Pilar
Boeing, Heiner
Dow, Courtney
Fagherazzi, Guy
Franks, Paul W.
Gonzalez, Carlos
Kaaks, Rudolf
Key, Timothy J.
Khaw, Kay Tee
Kühn, Tilman
Mortensen, Lotte Maxild
Nilsson, Peter M.
Overvad, Kim
Pala, Valeria
Palli, Domenico
Panico, Salvatore
Quirós, J. Ramón
Rodriguez-Barranco, Miguel
Rolandsson, Olov
Sacerdote, Carlotta
Scalbert, Augustin
Slimani, Nadia
Spijkerman, Annemieke M. W.
Tjonneland, Anne
Tormo, Maria-Jose
Tumino, Rosario
van der A, Daphne L.
van der Schouw, Yvonne T.
Langenberg, Claudia
Riboli, Elio
Wareham, Nicholas J.
Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study
title Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study
title_full Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study
title_fullStr Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study
title_full_unstemmed Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study
title_short Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study
title_sort association of plasma phospholipid n-3 and n-6 polyunsaturated fatty acids with type 2 diabetes: the epic-interact case-cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951144/
https://www.ncbi.nlm.nih.gov/pubmed/27434045
http://dx.doi.org/10.1371/journal.pmed.1002094
work_keys_str_mv AT forouhinitag associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT imamurafumiaki associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT sharpstephenj associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT koulmanalbert associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT schulzematthiasb associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT zhengjusheng associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT yezheng associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT sluijsivonne associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT guevaramarcela associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT huertajosemaria associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT krogerjanine associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT wanglaurayun associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT summerhillkeith associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT griffinjulianl associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT feskensedithjm associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT affretaurelie associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT amianopilar associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT boeingheiner associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT dowcourtney associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT fagherazziguy associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT frankspaulw associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT gonzalezcarlos associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT kaaksrudolf associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT keytimothyj associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT khawkaytee associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT kuhntilman associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT mortensenlottemaxild associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT nilssonpeterm associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT overvadkim associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT palavaleria associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT pallidomenico associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT panicosalvatore associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT quirosjramon associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT rodriguezbarrancomiguel associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT rolandssonolov associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT sacerdotecarlotta associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT scalbertaugustin associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT slimaninadia associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT spijkermanannemiekemw associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT tjonnelandanne associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT tormomariajose associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT tuminorosario associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT vanderadaphnel associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT vanderschouwyvonnet associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT langenbergclaudia associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT ribolielio associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy
AT warehamnicholasj associationofplasmaphospholipidn3andn6polyunsaturatedfattyacidswithtype2diabetestheepicinteractcasecohortstudy